Capital Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Capital Bank & Trust's GILD Position: Q3 2021 in Review
Capital Bank & Trust sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 869,698 shares — an estimated $59.9M sold.
Capital Bank & Trust first reported a position in GILD in Q2 2017 and held it in 17 quarters. The position peaked at $105M in Q3 2018. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.
- Capital Bank & Trust reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
- Capital Bank & Trust sold 869,698 Gilead Sciences shares in Q3 2021, an estimated $59.9M.
- Capital Bank & Trust first reported a position in Gilead Sciences in Q2 2017 and held it in 17 quarters.
- Capital Bank & Trust's Gilead Sciences position peaked at $105M in Q3 2018.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.
Based on Capital Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.